Clinical Trial Update: A Study to Investigate the Glucose Lowering Effects of Dextromethorphan Alone or in Combination With Sitagliptin in Subjects With Type 2 Diabetes Mellitus (T2DM) After an Oral Glucose Tolerance Test [Phase 2]

View source ↗

Summary

A completed Phase 2 clinical trial evaluating the glucose-lowering effects of dextromethorphan alone or in combination with sitagliptin in subjects with Type 2 …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Dextromethorphan (dextromethorphan)
• Sitagliptin (sitagliptin)

Snippet

Sponsor: Profil Institut für Stoffwechselforschung GmbH | Conditions: Type 2 Diabetes Mellitus | Phase 2 | Status: COMPLETED